Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: A pathologic, cytogenetic, and molecular study of a case with a novel translocation t(9;17)(q22;q11.2)

American Journal of Surgical Pathology

Volumn 24, Issue 7, 2000, Pages 1020-1026

  Harris, M ^a   Coyne, J ^b   Tariq, M ^a   Eyden, B P ^a   Atkinson, M ^d   Freemont, A J ^d   Varley, J ^c   Attwooll, C ^c   Telford, N ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b WITHINGTON HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d NONE

Author keywords

CHN; Extraskeletal myxoid chondrosarcoma; Histochemistry; Immunohistochemistry; Neuroendocrine differentiation; RBP56 hTAF(II)68; T(9; 17)(q2 2; q11.2); Ultrastructure

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHONDROSARCOMA; CHROMOSOME 17; CHROMOSOME TRANSLOCATION 9; CYTOGENETICS; GENE FUSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR GENETICS; MYXOSARCOMA; NEUROENDOCRINE TUMOR; TUMOR DIFFERENTIATION;

BUTTOCKS; CELL DIFFERENTIATION; CHONDROSARCOMA; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 9; CYTOGENETICS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NEUROSECRETORY SYSTEMS; PROCOLLAGEN; RNA, MESSENGER; RNA, NEOPLASM; SILVER STAINING; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0033932515     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200007000-00015     Document Type: Article

References (28)

1. Andrew JG, Hoyland JA, Andrew SM, Marsh D, Freemont AJ. Demonstration of TGF-B1 in normally healing fracture callus by in-situ hybridisation. Calcif Tissue Int 1993;52:74-8.
2. Andrew JG, Hoyland JA, Freemont AJ, Marsh DR. Platelet derived growth factor expression in normally healing human fractures. Bone 1995;16:455-60.
3. Antonescu CR, Argani P, Erlandson RA, Healey JH, Ladanyi M, Huvos AG. Skeletal and extraskeletal myxoid chondrosarcoma. A comparative clinicopathologic, ultrastructural, and molecular study. Cancer 1998;83:1504-21.
4. Attwooll C. Tariq M, Harris M, Coyne JD, Telford N, Varley JM. Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9:17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma. Oncogene 1999;18:7599-601.
5. Brody RI, Ueda T, Hamelin A, et al. Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma. Am J Pathol 1997;150:1049-58.
6. Chhieng DC, Erlandson RA, Antonescu C, Ladanyi M, Rosai J. Neuroendocrine differentiation in adult soft tissue sarcoma with features of extraskeletal myxoid chondrosarcoma: report of seven cases [Abstract]. Mod Pathol 1998;11:8A.
7. Christensen WN, Strong EW, Bains MS, Woodruff JM. Neuroendocrine differentiation in glandular peripheral nerve sheath tumor. Pathologic distinction from the biphasic synovial sarcoma with glands. Am J Surg Pathol 1988;12:417-26.
8. Dehner LP. Primitive neuroectodermal tumor and Ewing's sarcoma. Am J Surg Pathol 1993;17:1-13.
9. Devlin H, Hoyland J, Freemont AJ, Sloan P. Localization of pro-collagen type II mRNA and collagen type II in the healing tooth socket of the rat. Arch Oral Biol 1995;40:181-5.
10. Ducatman BS, Scheithauer BW. Malignant peripheral nerve sheath tumours with divergent differentiation. Cancer 1984;54:1049-57.
11. Enzinger FM, Shiraki M. Extraskeletal myxoid chondrosarcoma. An analysis of 34 cases. Hum Pathol 1972;3:421-35.
12. Fletcher CDM, Powell G, McKee PH. Extraskeletal myxoid chondrosarcoma: a histochemical and immunohistochemical study. Histopathology 1986;10:489-99.
13. Hirabayashi Y, Ishida T, Yoshida MA, et al. Translocation (9;22)(q22;q12). Recurrent chromosome abnormality in extraskeletal myxoid chondrosarcoma. Cancer Genet Cytogenet 1995;81: 33-7.
14. Labelle Y, Zucman J, Stenman G, et al. Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum Mol Genet 1995;4:2219-26.
15. Mark-Vendel E, Terrier P, Turc-Carel C. Re-arrangement of 9q22: a crucial event in extraskeletal myxoid chondrosarcoma [Abstract]. Cancer Genet Cytogenet 1991;52:267.
16. Meis-Kindblom JM, Bergh P, Gunterberg B, Kindblom LG. Extraskeletal myxoid chondrosarcoma. A reappraisal of its morphologic spectrum and prognostic factors based on 117 cases. Am J Surg Pathol 1999;23:636-50.
17. Oliveira AM, Gaffey TA, Rock MG, Nascimento AG. Extraskeletal myxoid chondrosarcoma: a study of 23 cases [Abstract]. Mod Pathol 1999;12:14A.
18. Orndal C, Carlen B, Akerman M, et al. Chromosomal abnormality t(9;22)(q22;q12) in an extraskeletal myxoid chondrosarcoma characterised by fine needle aspiration cytology, electron microscopy, immunohistochemistry and DNA flow cytometry. Cytopathology 1991;2:261-70.
19. Panagopoulos I, Mencinger M, Dietrick CU, et al. Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t(9;17)(q22:q11). Oncogene 1999;18:7594-8.
20. Pearson JM, Harris M, Eyden BP, Banerjee SS. Divergent differentiation in small round cell tumours of the soft tissues with neural features - an analysis of 10 cases. Histopathology 1993;23:1-9.
21. Sciot R. Dal Cin P, Fletcher C. et al. t(9;22)(q22-31; q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases. Mod Pathol 1995;8:765-8.
22. Scott JE, Dorling J. Differential staining of acid glycosaminoglycan (mucopolysaccharides) by Alcian blue in salt solutions. Histochemie 1965;5:221-33.
23. Sjogren H, Meis-Kindblom J, Kindblom L-G, Aman P, Stenman G. Fusion of the EWS-related TAF2N to TEC in extraskeletal myxoid chondrosarcoma. Cancer Res 1999;59:5064-7.
24. Stenman G, Anderson H, Mandahl N, Meis-Kindblom JM, Kindblom L-G. Translocation t(9;22)(q22;q12) is a primary cytogenetic abnormality in extraskeletal myxoid chondrosarcoma. Int J Cancer 1995;62:398-402.
25. Turc-Carel C, Dal Cin P, Rao U, Karakousis C, Sandberg AA. Recurrent break points at 9q31 and 22q12.2 in extraskeletal myxoid chondrosarcoma. Cancer Genet Cytogenet 1988;30:145-50.
26. Vennegoor C, Calafat J, Hageman PH, et al. Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/ C3. Int J Cancer 1985;35:287-95.
27. Warner TFCS, Louie R. Malignant nerve sheath tumor containing endocrine cells. Am J Surg Pathol 1983;7:583-90.
28. Woodruff JM. Peripheral nerve sheath tumours showing glandular differentiation (glandular schwannomas). Cancer 1976;37:2399-413.